Apriss logo
Vermont Adopts Appriss' Platform to Mitigate Drug Diversion
January 11, 2016 11:05 ET | Appriss
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont...
Apriss logo
Ohio Selects Appriss' PMP Gateway to Enhance Interoperability of OARRS Platform
December 01, 2015 10:49 ET | Appriss
LOUISVILLE, Ky., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that is has signed an...
Apriss logo
Palmetto Health Takes Steps to Prevent Prescription Drug Abuse
November 09, 2015 10:31 ET | Appriss
LOUISVILLE, Ky., Nov. 9, 2015 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention (CDC) calls the misuse and abuse of prescription medications a nationwide epidemic. According to the...
Apriss logo
South Carolina Awards Contract to Appriss for New Prescription Monitoring Solution
September 16, 2015 11:06 ET | Appriss
LOUISVILLE, Ky., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of South...
Apriss logo
Kroger Introduces Appriss' NARxCHECK(TM) into Pharmacies
August 12, 2015 11:51 ET | Appriss
LOUISVILLE, Ky., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that The Kroger Co. has...
Apriss logo
Cerner Integrates NARxCHECK(TM) Into Electronic Health Record System
August 06, 2015 10:30 ET | Appriss
LOUISVILLE, Ky., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that Cerner (Nasdaq: CERN),...
Apriss logo
South Dakota Adopts Appriss Platform to Mitigate Drug Diversion
July 01, 2015 12:12 ET | Appriss
LOUISVILLE, Ky., July 1, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of South...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
April 22, 2014 07:41 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the issuance of U.S. Patent No. 8,703,186 titled...
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
March 02, 2012 06:30 ET | Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Mar 2, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced independent laboratory...
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
October 17, 2011 06:00 ET | Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...